Mitchell Strain

Title: Innovations by Inventor Mitchell Strain in Heart Surgery

Introduction: Mitchell Strain, an accomplished inventor based in Saint Paul, MN, has made significant contributions to the field of medical technology. He holds three patents, with his latest innovations focusing on improving surgical techniques related to cardiac procedures.

Latest Patents: One of Mitchell Strain's most notable patents is the "Subxiphoid Connective Lesion Ablation System and Method." This innovative instrument is designed for applying ablative energy to epicardial tissue through a subxiphoid access surgical approach. The device features a head assembly tailored to facilitate surgery on a patient's heart, equipped with a contact face. It includes a paddle body, alongside first and second ablation electrodes that are uniquely arranged and fixed in position. These ablation electrodes are strategically exposed at the contact face, ensuring effective energy delivery during surgical procedures. A tubular member extends from the head assembly, maintaining the necessary wiring to the ablation electrodes. This instrument allows for precise placement on epicardial tissue within the heart, particularly between the left and right pulmonary vein junctions of the posterior left atrium.

Career Highlights: Mitchell Strain's career has been marked by his role at Medtronic, Inc., a leading company in medical technology. His work has focused on developing groundbreaking solutions that enhance surgical procedures, particularly in the realm of cardiac care.

Collaborations: Throughout his career, Mitchell has collaborated with notable professionals, including coworkers James R. Skarda and Steven F. Bolling. These partnerships have undoubtedly contributed to the advancement of his innovative ideas and the successful implementation of his patented technologies.

Conclusion: Mitchell Strain exemplifies the spirit of innovation within the medical field, particularly through his work in cardiac surgery. His patented inventions, including the subxiphoid connective lesion ablation system, continue to pave the way for improved surgical practices, demonstrating the impact that dedicated inventors can have on healthcare advancements.